tiprankstipranks

Cary Claiborne Insider Profile

4 Followers
Cary Claiborne, Former Chief Financial Officer at Sucampo Pharmaceuticals, holds 1.52M shares in Adial Pharmaceuticals (Ticker: ADIL), holds 2.86K shares in Sucampo Pharmaceuticals (Ticker: SCMP), holds ― shares in LadRx (Ticker: LADX).
tipranks
Cary Claiborne

Cary Claiborne
Sucampo Pharmaceuticals (SCMP)
Former Chief Financial Officer

Not Ranked
Cary Claiborne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of Cary Claiborne's holdings

Insider Roles

Adial Pharmaceuticals
(ADIL)
CEO, Director
LadRx
(LADX)
Director
Roles that Cary Claiborne holds in companies

Most Profitable Insider Trade

Stock:
Sucampo Pharmaceuticals
(SCMP)
Rating:Informative Sell
Date:Dec 17, 2014 - Dec 17, 2015
Return:-30.10%
The most profitable trade made by Cary Claiborne

Cary Claiborne's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCMP
Sucampo Pharmaceuticals
Dec 17, 2014
Informative Sell
645.36K
$51.55K
Adial Pharmaceuticals
May 25, 2023
CEO, Director
Uninformative Buy
$2.58M
LadRx
Director
OSIR
Osiris Therapeutics Inc
$1.42M
List of latest transactions for each holding click on a transaction to see Cary Claiborne's performance on stock

Cary Claiborne insider profile FAQ

What is the percentage of profitable transactions made by Cary Claiborne?
The percentage of profitable transactions made by Cary Claiborne is ―.
    What is the average return per transaction made by Cary Claiborne?
    The average return per transaction made by Cary Claiborne is ―.
      What stocks does Cary Claiborne hold?
      Cary Claiborne holds: SCMP, ADIL, LADX, OSIR stocks.
        What was Cary Claiborne’s latest transaction?
        Cary Claiborne latest transaction was an Uninformative Buy of ―.
          What was Cary Claiborne's most profitable transaction?
          Cary Claiborne’s most profitable transaction was an Informative Sell of SCMP stock on December 17, 2014. The return on the trade was -30.10%.
            What is Cary Claiborne's role in Sucampo Pharmaceuticals?
            Cary Claiborne's role in Sucampo Pharmaceuticals is Former Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.